HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasushi Saito Selected Research

Hypercholesterolemia

1/2012The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid.
11/2011Pitavastatin: an overview.
7/2010Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease.
3/2010Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.
3/2010Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia.
10/2009Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
6/2009Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).
12/2008Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).
9/2008Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
8/2008Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasushi Saito Research Topics

Disease

27Hypercholesterolemia
01/2012 - 06/2002
23Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 04/2002
23Atherosclerosis
01/2012 - 01/2002
13Insulin Resistance
11/2011 - 01/2004
13Inflammation (Inflammations)
05/2009 - 01/2002
12Hypertension (High Blood Pressure)
02/2021 - 01/2003
11Type 2 Diabetes Mellitus (MODY)
09/2017 - 10/2002
10Coronary Disease (Coronary Heart Disease)
02/2021 - 01/2002
10Dyslipidemias (Dyslipidemia)
02/2021 - 05/2002
10Neoplasms (Cancer)
08/2017 - 11/2003
9Diabetes Mellitus
01/2012 - 01/2003
8Hypertriglyceridemia
11/2013 - 01/2003
8Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2011 - 01/2003
7Werner Syndrome (Werner's Syndrome)
01/2012 - 09/2004
7Obesity
04/2011 - 01/2003
7Hyperplasia
01/2009 - 01/2005
6Infections
04/2022 - 02/2003
6Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2021 - 02/2002
6Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 01/2002
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2012 - 12/2003
5Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
08/2022 - 02/2011
5Vascular Diseases (Vascular Disease)
05/2009 - 01/2004
5Hyperlipidemias (Hyperlipidemia)
01/2004 - 01/2002
4Graft vs Host Disease (Graft-Versus-Host Disease)
11/2019 - 12/2002
4Myocardial Infarction
01/2018 - 01/2002
4Body Weight (Weight, Body)
01/2013 - 01/2003
4Leukemia
10/2012 - 11/2003
4Ulcerative Colitis
07/2010 - 05/2002
4Acth-Independent Macronodular Adrenal Hyperplasia
01/2009 - 02/2004
4Cushing Syndrome
01/2009 - 02/2004
3Hepatocellular Carcinoma (Hepatoma)
02/2019 - 11/2014
3Liver Diseases (Liver Disease)
01/2017 - 06/2005
3Colitis
02/2010 - 03/2003
3Adenoma (Adenomas)
01/2009 - 10/2008
3Hepatitis
08/2008 - 12/2002
3Rhabdomyolysis
10/2007 - 01/2003
3Atherosclerotic Plaque (Atheroma)
05/2007 - 01/2002
3Glucose Intolerance
05/2007 - 09/2004
3Diabetic Neuropathies (Diabetic Neuropathy)
11/2004 - 03/2002
2Hypersensitivity (Allergy)
04/2022 - 06/2002
2Xanthomatosis (Xanthoma)
02/2021 - 06/2016
2Hemorrhage
01/2020 - 03/2016
2Vasculitis (Vasculitides)
07/2019 - 02/2003
2Edema (Dropsy)
08/2017 - 05/2003
2Neoplasm Metastasis (Metastasis)
11/2015 - 01/2015
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2013 - 10/2005
2Weight Loss (Weight Reduction)
01/2013 - 09/2004
2Hypoxia (Hypoxemia)
08/2011 - 04/2008

Drug/Important Bio-Agent (IBA)

35LipidsIBA
10/2022 - 01/2002
24Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022 - 01/2002
19Triglycerides (Triacylglycerol)IBA
11/2013 - 04/2002
18oxidized low density lipoproteinIBA
02/2021 - 02/2002
16CholesterolIBA
04/2010 - 01/2002
15LDL CholesterolIBA
10/2022 - 01/2002
15pitavastatin (itavastatin)FDA Link
10/2022 - 01/2002
15HDL CholesterolIBA
01/2022 - 04/2002
9Pharmaceutical PreparationsIBA
02/2019 - 06/2002
9Simvastatin (Zocor)FDA LinkGeneric
03/2010 - 12/2002
8Messenger RNA (mRNA)IBA
01/2018 - 01/2002
8Eicosapentaenoic AcidIBA
05/2013 - 07/2008
8CytokinesIBA
01/2013 - 01/2003
8Glucose (Dextrose)FDA LinkGeneric
10/2009 - 01/2004
7Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2004
7Lipoproteins (Lipoprotein)IBA
08/2014 - 02/2002
6AntigensIBA
04/2022 - 06/2002
6Insulin (Novolin)FDA Link
01/2012 - 06/2002
5LDL Lipoproteins (beta Lipoproteins)IBA
02/2021 - 10/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2008 - 10/2005
5Pioglitazone (Actos)FDA Link
01/2008 - 09/2004
5Pravastatin (Pravachol)FDA LinkGeneric
07/2006 - 01/2002
4Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA
08/2022 - 02/2011
4Probucol (Lorelco)FDA Link
06/2022 - 12/2008
4Transforming Growth Factor beta (TGF-beta)IBA
02/2009 - 01/2004
4Hydrocortisone (Cortisol)FDA LinkGeneric
01/2009 - 02/2004
4Vasopressins (Vasopressin)IBA
01/2009 - 02/2004
3Capsules (Microcapsules)IBA
07/2019 - 03/2016
3SteroidsIBA
07/2019 - 02/2004
3Malondialdehyde (Propanedial)IBA
10/2015 - 04/2002
3eicosapentaenoic acid ethyl esterIBA
11/2013 - 01/2013
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2013 - 03/2007
3Advanced Glycation End ProductsIBA
09/2010 - 05/2007
3DNA (Deoxyribonucleic Acid)IBA
08/2008 - 11/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
03/2008 - 02/2004
33-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2003 - 05/2002
2Immunoglobulin E (IgE)IBA
04/2022 - 01/2006
2AntioxidantsIBA
02/2021 - 12/2008
2Immunoglobulins (Immunoglobulin)IBA
07/2019 - 08/2008
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2017 - 04/2007
2RNA (Ribonucleic Acid)IBA
01/2017 - 08/2011
2TAK-085IBA
11/2013 - 05/2013
24,7,10,13,16,19-docosahexaenoic acid ethyl esterIBA
11/2013 - 05/2013
2DNA HelicasesIBA
01/2012 - 08/2008
2Atorvastatin (Lipitor)FDA Link
11/2011 - 12/2008

Therapy/Procedure

25Therapeutics
10/2022 - 05/2002
5Secondary Prevention
02/2021 - 12/2002
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2005 - 09/2002
3Drug Therapy (Chemotherapy)
01/2018 - 10/2012
3Glycemic Control
09/2017 - 11/2002
3Blood Component Removal (Apheresis)
11/2006 - 04/2004
2Cell- and Tissue-Based Therapy (Cell Therapy)
08/2022 - 05/2006